Portions of this exhibit marked [*] are requested to be treated confidentially. DCVAX-DIRECT MANUFACTURING AND SERVICES AGREEMENTServices Agreement • December 12th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 12th, 2014 Company Industry JurisdictionThis Services Agreement (this “Agreement”) is entered into, effective as of January 17, 2014(the “Effective Date”), by and between Cognate BioServices, a Delaware corporation (Cognate”), and Northwest Biotherapeutics, a Delaware corporation (“NW Bio”).
Portions of this exhibit marked [*] are requested to be treated confidentially. DCVAX®-L MANUFACTURING AND SERVICES AGREEMENTServices Agreement • December 12th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 12th, 2014 Company Industry JurisdictionThis Amended and Restated Services Agreement (this “Agreement”), originally dated April 1, 2011 is entered into, effective as of January 17, 2014 (the “Effective Date”), by and between Cognate BioServices, a Delaware corporation (Cognate”), and Northwest Biotherapeutics, a Delaware corporation (“NW Bio”).
Portions of this exhibit marked [*] are requested to be treated confidentially. DCVAX-DIRECT MANUFACTURING AND SERVICES AGREEMENTServices Agreement • May 15th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMay 15th, 2014 Company Industry JurisdictionThis Services Agreement (this “Agreement”) is entered into, effective as of January 17, 2014(the “Effective Date”), by and between Cognate BioServices, a Delaware corporation (Cognate”), and Northwest Biotherapeutics, a Delaware corporation (“NW Bio”).